InvestorsHub Logo
Followers 55
Posts 11258
Boards Moderated 2
Alias Born 04/25/2012

Re: NewJerichoMan post# 3668

Friday, 11/17/2017 9:34:36 AM

Friday, November 17, 2017 9:34:36 AM

Post# of 11429
We'll find out soon enough if yesterday is a reversal or a head fake.

On a side note, Maxim lowered our price target from $7.50 to $6 but reiterated buy rating.

Missed 3Qs in a row so they had to downgrade the PT to save face.

Due to the 3Q17 miss and our expectations, we are lowering our 2017, 2018, and 2019 revenue estimates to $55.5M, $72.2M, $83.5M, from $62.4M, $83.6M, and $96.7M. As a result of these lower revenues, we are also lowering our 2017, 2018, and 2019 GAAP EPS estimates to $0.02, $0.08, and $0.17, from $0.10, $0.19, and $0.27.



Maxim attributes the miss to the yet-to-be-stabilized sales of Coco and Marley. Their miss was $3.8M on the topline. That's 20%. Savings / synergies in the cost structures weren't realized either.

I think we can surmise that Xing was also part of that decline. We know distribution grew 6% and Maxim puts that at $30M+ in its initial report. Bucha, we can't be sure, but it's probably growing. Aspen Pure is definitely growing because of APP. Those 3 are not enough, obviously, to offset the other decliners.

Maxim's Q4 estimate is now $14.6M, which would equate to $55.5M (GAAP) for 2017. Pro forma for 2017 would be around ~$60M. For reference, the pro forma of the entire company, as currently constituted, was ~$70M in 2016, about a 15% decline YoY.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.